Dossier
phase I clinical trial
Coverage of phase I clinical trial in the Nexus archive.
- Montana’s new “right to try” law can’t come soon enough for some
Kris DeVault's son Brody has creatine transporter deficiency, a rare genetic condition with no cure. A French biotech company, Ceres Brain Therapeutics, is developing an experimental nasal spray drug for the condition, currently in early testing phases. Montana's new 'right to try' law may help families like the DeVaults access unapproved treatments.